O	0	10	Evaluation
O	11	13	of
B-Symptom	14	21	retinal
I-Symptom	22	27	nerve
I-Symptom	28	33	fiber
I-Symptom	34	39	layer
I-Symptom	40	51	progression
O	52	54	in
B-Disease	55	63	glaucoma
O	64	65	a
O	66	77	prospective
O	78	86	analysis
O	87	91	with
B-Anatomy	92	104	neuroretinal
I-Anatomy	105	108	rim
O	109	112	and
B-Symptom	113	119	visual
I-Symptom	120	125	field
I-Symptom	126	137	progression
O	137	138	.

O	140	142	To
O	143	151	evaluate
O	152	155	the
O	156	167	performance
O	168	170	of
O	171	182	progression
O	183	192	detection
O	193	196	and
O	197	200	the
O	201	205	rate
O	206	208	of
O	209	215	change
O	216	218	of
B-Anatomy	219	226	retinal
I-Anatomy	227	232	nerve
I-Anatomy	233	238	fiber
I-Anatomy	239	244	layer
O	245	246	(
B-Anatomy	246	250	RNFL
O	250	251	)
O	251	252	,
B-Anatomy	253	265	neuroretinal
I-Anatomy	266	269	rim
O	269	270	,
O	271	274	and
B-Characteristic	275	281	visual
I-Characteristic	282	287	field
O	288	300	measurements
O	301	303	in
B-Disease	304	312	glaucoma
O	312	313	.

O	314	325	Prospective
O	326	331	study
O	331	332	.

O	333	336	One
O	337	344	hundred
O	345	350	eight
B-Anatomy	351	355	eyes
O	356	358	of
O	359	361	70
B-Disease	362	370	glaucoma
O	371	379	patients
O	379	380	.

O	381	389	Patients
O	390	394	were
O	395	403	followed
O	404	406	up
O	407	412	every
O	413	414	4
O	415	421	months
O	422	425	for
O	426	428	at
O	429	434	least
O	435	436	2
O	436	437	.
O	437	438	9
O	439	444	years
O	445	446	(
O	446	452	median
O	452	453	,
O	454	455	3
O	455	456	.
O	456	457	2
O	458	463	years
O	463	464	)
O	465	468	for
O	469	480	measurement
O	481	483	of
B-Characteristic	484	488	RNFL
I-Characteristic	489	498	thickness
O	499	503	with
O	504	507	the
B-Diagnostic_tool	508	515	Stratus
I-Diagnostic_tool	516	523	optical
I-Diagnostic_tool	524	533	coherence
I-Diagnostic_tool	534	543	tomograph
O	544	545	(
B-Diagnostic_tool	545	548	OCT
O	548	549	)
O	550	551	(
O	551	555	Carl
O	556	561	Zeiss
O	562	569	Meditec
O	569	570	,
O	571	577	Dublin
O	577	578	,
O	579	581	CA
O	581	582	)
O	582	583	,
B-Characteristic	584	596	neuroretinal
I-Characteristic	597	600	rim
I-Characteristic	601	605	area
O	606	610	with
O	611	614	the
B-Diagnostic_tool	615	625	Heidelberg
I-Diagnostic_tool	626	633	Retinal
I-Diagnostic_tool	634	643	Tomograph
O	644	645	(
B-Diagnostic_tool	645	648	HRT
O	649	650	3
O	650	651	;
O	652	662	Heidelberg
O	663	674	Engineering
O	674	675	,
O	676	680	GmbH
O	680	681	,
O	682	692	Dossenheim
O	692	693	,
O	694	701	Germany
O	701	702	)
O	702	703	,
O	704	707	and
B-Characteristic	708	714	visual
I-Characteristic	715	720	field
O	721	725	with
O	726	729	the
B-Diagnostic_tool	730	738	Humphrey
I-Diagnostic_tool	739	744	Field
I-Diagnostic_tool	745	753	Analyzer
I-Diagnostic_tool	754	756	II
O	757	758	(
O	758	762	Carl
O	763	768	Zeiss
O	769	776	Meditec
O	776	777	)
O	777	778	.

O	779	785	Linear
O	786	796	regression
O	797	805	analyses
O	806	810	were
O	811	820	performed
O	821	828	between
B-Characteristic	829	835	visual
I-Characteristic	836	841	field
I-Characteristic	842	847	index
O	848	849	(
B-Characteristic	849	852	VFI
O	852	853	)
O	853	854	,
B-Anatomy	855	859	RNFL
O	859	860	,
O	861	864	and
B-Anatomy	865	877	neuroretinal
I-Anatomy	878	881	rim
O	882	894	measurements
O	895	898	and
B-Characteristic	899	902	age
O	902	903	,
O	904	908	with
O	909	920	progression
O	921	928	defined
O	929	933	when
O	934	935	a
O	936	947	significant
O	948	956	negative
O	957	962	trend
O	963	966	was
O	967	975	detected
O	975	976	.

O	977	980	The
O	981	990	agreement
O	991	996	among
O	997	1007	structural
O	1008	1011	and
O	1012	1022	functional
O	1023	1035	measurements
O	1036	1039	was
O	1040	1049	evaluated
O	1050	1054	with
O	1055	1056	κ
O	1057	1067	statistics
O	1067	1068	.

O	1069	1072	The
O	1073	1077	mean
O	1078	1082	rate
O	1083	1085	of
O	1086	1092	change
O	1093	1096	was
O	1097	1106	estimated
O	1107	1111	with
O	1112	1118	linear
O	1119	1124	mixed
O	1125	1133	modeling
O	1133	1134	.

O	1135	1138	The
O	1139	1148	agreement
O	1149	1151	on
O	1152	1163	progression
O	1164	1173	detection
O	1174	1177	and
O	1178	1181	the
O	1182	1186	rate
O	1187	1189	of
O	1190	1196	change
O	1197	1199	of
B-Anatomy	1200	1204	RNFL
O	1204	1205	,
B-Anatomy	1206	1218	neuroretinal
I-Anatomy	1219	1222	rim
O	1222	1223	,
O	1224	1227	and
B-Characteristic	1228	1231	VFI
O	1232	1244	measurements
O	1244	1245	.

O	1246	1247	A
O	1248	1253	total
O	1254	1256	of
O	1257	1261	1105
B-Diagnostic_tool	1262	1265	OCT
O	1265	1266	,
O	1267	1271	1062
B-Diagnostic_tool	1272	1275	HRT
O	1275	1276	,
O	1277	1280	and
O	1281	1285	1099
B-Characteristic	1286	1292	visual
I-Characteristic	1293	1298	field
O	1299	1311	measurements
O	1312	1316	were
O	1317	1325	analyzed
O	1325	1326	.

O	1327	1330	The
O	1331	1340	agreement
O	1341	1343	of
O	1344	1355	progression
O	1356	1365	detection
O	1366	1371	among
O	1372	1375	the
O	1376	1377	3
O	1378	1392	investigations
O	1393	1396	was
O	1397	1401	poor
O	1402	1403	(
O	1403	1404	κ
O	1404	1405	≤
O	1405	1406	0
O	1406	1407	.
O	1407	1409	09
O	1409	1410	)
O	1410	1411	.

O	1412	1415	Ten
B-Anatomy	1416	1420	eyes
O	1421	1422	(
O	1422	1423	9
O	1423	1424	.
O	1424	1425	3
O	1425	1426	%
O	1426	1427	;
O	1428	1429	9
O	1430	1438	patients
O	1438	1439	)
O	1440	1446	showed
O	1447	1458	progression
O	1459	1461	by
O	1462	1469	average
B-Characteristic	1470	1474	RNFL
I-Characteristic	1475	1484	thickness
O	1484	1485	,
O	1486	1488	16
O	1489	1490	(
O	1490	1492	14
O	1492	1493	.
O	1493	1494	8
O	1494	1495	%
O	1495	1496	;
O	1497	1499	14
O	1500	1508	patients
O	1508	1509	)
O	1510	1512	by
O	1513	1519	global
B-Characteristic	1520	1532	neuroretinal
I-Characteristic	1533	1536	rim
I-Characteristic	1537	1541	area
O	1541	1542	,
O	1543	1546	and
O	1547	1549	35
O	1550	1551	(
O	1551	1553	32
O	1553	1554	.
O	1554	1555	4
O	1555	1556	%
O	1556	1557	;
O	1558	1560	31
O	1561	1569	patients
O	1569	1570	)
O	1571	1573	by
B-Characteristic	1574	1577	VFI
O	1577	1578	.

O	1579	1583	Only
O	1584	1585	1
B-Anatomy	1586	1589	eye
O	1590	1591	(
O	1591	1592	0
O	1592	1593	.
O	1593	1594	9
O	1594	1595	%
O	1595	1596	)
O	1597	1600	had
O	1601	1612	progression
O	1613	1621	detected
O	1622	1624	by
O	1625	1628	all
O	1629	1630	3
O	1631	1638	methods
O	1638	1639	.

O	1640	1645	There
O	1646	1650	were
O	1651	1656	large
O	1657	1667	variations
O	1668	1670	in
O	1671	1674	the
O	1675	1679	rate
O	1680	1682	of
O	1683	1689	change
O	1690	1692	of
B-Characteristic	1693	1696	VFI
O	1696	1697	,
O	1698	1705	average
B-Characteristic	1706	1710	RNFL
I-Characteristic	1711	1720	thickness
O	1720	1721	,
O	1722	1725	and
O	1726	1732	global
B-Characteristic	1733	1745	neuroretinal
I-Characteristic	1746	1749	rim
I-Characteristic	1750	1754	area
O	1754	1755	,
O	1756	1760	with
O	1761	1762	a
O	1763	1768	range
O	1769	1776	between
O	1777	1778	-
O	1778	1779	0
O	1779	1780	.
O	1780	1782	63
O	1782	1783	%
O	1784	1787	and
O	1788	1789	-
O	1789	1790	4
O	1790	1791	.
O	1791	1793	97
O	1793	1794	%
O	1795	1798	per
O	1799	1803	year
O	1803	1804	,
O	1805	1806	-
O	1806	1807	2
O	1807	1808	.
O	1808	1810	32
O	1810	1811	%
O	1812	1815	and
O	1816	1817	-
O	1817	1819	10
O	1819	1820	.
O	1820	1822	12
O	1822	1823	%
O	1824	1827	per
O	1828	1832	year
O	1832	1833	,
O	1834	1837	and
O	1838	1839	-
O	1839	1840	0
O	1840	1841	.
O	1841	1843	61
O	1843	1844	%
O	1845	1848	and
O	1849	1850	-
O	1850	1851	8
O	1851	1852	.
O	1852	1854	48
O	1854	1855	%
O	1856	1859	per
O	1860	1864	year
O	1864	1865	,
O	1866	1878	respectively
O	1878	1879	.

O	1880	1883	The
O	1884	1894	respective
O	1895	1899	mean
O	1900	1904	rate
O	1905	1914	estimates
O	1915	1919	were
O	1920	1921	-
O	1921	1922	1
O	1922	1923	.
O	1923	1925	15
O	1925	1926	%
O	1927	1930	per
O	1931	1935	year
O	1936	1937	(
O	1937	1939	95
O	1939	1940	%
O	1941	1951	confidence
O	1952	1960	interval
O	1961	1962	[
O	1962	1964	CI
O	1964	1965	]
O	1965	1966	,
O	1967	1968	-
O	1968	1969	1
O	1969	1970	.
O	1970	1972	56
O	1972	1973	%
O	1974	1976	to
O	1977	1978	-
O	1978	1979	0
O	1979	1980	.
O	1980	1982	73
O	1982	1983	%
O	1983	1984	)
O	1984	1985	,
O	1986	1987	-
O	1987	1988	0
O	1988	1989	.
O	1989	1991	70
O	1991	1992	%
O	1993	1996	per
O	1997	2001	year
O	2002	2003	(
O	2003	2005	95
O	2005	2006	%
O	2007	2009	CI
O	2009	2010	,
O	2011	2012	-
O	2012	2013	1
O	2013	2014	.
O	2014	2016	19
O	2016	2017	%
O	2018	2020	to
O	2021	2022	-
O	2022	2023	0
O	2023	2024	.
O	2024	2026	21
O	2026	2027	%
O	2027	2028	)
O	2028	2029	,
O	2030	2033	and
O	2034	2035	-
O	2035	2036	1
O	2036	2037	.
O	2037	2039	06
O	2039	2040	%
O	2041	2044	per
O	2045	2049	year
O	2050	2051	(
O	2051	2053	95
O	2053	2054	%
O	2055	2057	CI
O	2057	2058	,
O	2059	2060	-
O	2060	2061	1
O	2061	2062	.
O	2062	2064	56
O	2064	2065	%
O	2066	2068	to
O	2069	2070	-
O	2070	2071	0
O	2071	2072	.
O	2072	2074	55
O	2074	2075	%
O	2075	2076	)
O	2076	2077	.

O	2078	2081	The
O	2082	2091	agreement
O	2092	2094	of
O	2095	2106	progression
O	2107	2116	detection
O	2117	2122	among
B-Anatomy	2123	2127	RNFL
O	2127	2128	,
B-Anatomy	2129	2141	neuroretinal
I-Anatomy	2142	2145	rim
O	2145	2146	,
O	2147	2150	and
B-Characteristic	2151	2157	visual
I-Characteristic	2158	2163	field
O	2164	2176	measurements
O	2177	2180	was
O	2181	2185	poor
O	2185	2186	,
O	2187	2190	and
O	2191	2194	the
O	2195	2199	rate
O	2200	2202	of
B-Anatomy	2203	2207	RNFL
O	2207	2208	,
B-Anatomy	2209	2221	neuroretinal
I-Anatomy	2222	2225	rim
O	2225	2226	,
O	2227	2230	and
B-Characteristic	2231	2237	visual
I-Characteristic	2238	2243	field
O	2244	2255	progression
O	2256	2262	varied
O	2263	2275	considerably
O	2276	2282	within
O	2283	2286	and
O	2287	2294	between
O	2295	2303	subjects
O	2303	2304	.

O	2305	2310	Given
O	2311	2315	this
O	2316	2327	variability
O	2327	2328	,
O	2329	2343	interpretation
O	2344	2346	of
B-Anatomy	2347	2351	RNFL
O	2351	2352	,
B-Anatomy	2353	2365	neuroretinal
I-Anatomy	2366	2369	rim
O	2369	2370	,
O	2371	2374	and
B-Characteristic	2375	2378	VFI
O	2379	2390	progression
O	2391	2397	always
O	2398	2404	should
O	2405	2407	be
O	2408	2417	evaluated
O	2418	2420	on
O	2421	2423	an
O	2424	2434	individual
O	2435	2440	basis
O	2440	2441	.

O	2442	2453	Proprietary
O	2454	2456	or
O	2457	2467	commercial
O	2468	2478	disclosure
O	2479	2482	may
O	2483	2485	be
O	2486	2491	found
O	2492	2497	after
O	2498	2501	the
O	2502	2512	references
O	2512	2513	.
